Interviews
View More
Chad Hatfield, Pharm.D., on preparing for a 340B rebate model | HSES 2026

Chad Hatfield, Pharm.D., of UC Davis Health, says rebate model readiness starts with a spend review and data that pharmacy and IT can pull consistently.

Chad Hatfield, Pharm.D., on the 340B uncertainty facing health systems| HSES 2026

Chad Hatfield, Pharm.D., of UC Davis Health, says 340B savings fund free clinics and mental health care that could shrink as the program’s future shifts.

Luis Garza, M.D., Ph.D., on what hidradenitis suppurativa is not

Luis Garza, M.D., Ph.D., a Johns Hopkins professor, says hidradenitis suppurativa is neither an infection nor a classic autoimmune disease but an auto-inflammatory condition.

Abdullah Ahmed, University of Illinois Chicago research fellow, on age and vision loss after burns | AAO 2026

Vision impairment affected 17.6% of 1,484 adult burn survivors in a study presented at AAO 2026, with age the strongest predictor of difficulty seeing.

Luis Garza, M.D., Ph.D., on possible chemical, dietary links to rising incidence of hidradenitis suppurativa

Hidradenitis suppurativa is becoming more common, and a Johns Hopkins expert suspects an unidentified chemical in processed foods may be one reason.

Jonathan Myers, M.D., on home VR perimetry and glaucoma reimbursement | AAO 2026

A two-year study of 53 glaucoma patients logged nearly 4,800 home VR visual field tests, yet no insurance code currently covers home perimetry.

Economics must align to scale CAR-T therapy access, per Dan Nardi of Reimagine Care

Reimagine Care's CEO says one-off hospital approvals slow CAR-T access and urges buyers to ask vendors to prove outcomes such as avoided ED visits.

Katie Martin, M.P.A., has 3 messages for employers paying healthcare costs

The financial pain from your healthcare cost is real, you are uniquely placed to negotiate prices down, and hospitals, at 46% of spending, are where to look, says the CEO and president of the Health Care Cost Institute, which issued its annual cost and utilization report today.

Katie Martin, M.P.A., on soaring prescription drug spending and relatively stable out-of-pocket costs

Spending on prescription drugs grew by 40%, faster than spending on inpatient care, outpatient care and professional services, according to a new report from the Health Care Cost Institute.

Advertisement
Advertisement

Official Media Partners